Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT02669940
What this trial is testing

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis CGenotype 1
AbbVie 158
Large-scale testing (Phase 3)Study completedNCT01728324
What this trial is testing

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 496
Large-scale testing (Phase 3)Study completedNCT01716585
What this trial is testing

Evaluate Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 636
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Large-scale testing (Phase 3)Study completedNCT01715415
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 395
Not applicableUnknownNCT03170076
What this trial is testing

Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs

Who this might be right for
Hepatitis C, Chronic
Assiut University 1
Not applicableUnknownNCT01151397
What this trial is testing

Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?

Who this might be right for
Chronic Hepatitis C
Ziv Hospital 60
Large-scale testing (Phase 3)Study completedNCT01725529
What this trial is testing

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 457
Testing effectiveness (Phase 2)Study completedNCT01012895
What this trial is testing

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 215
Testing effectiveness (Phase 2)Study completedNCT00336479
What this trial is testing

Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 263
Large-scale testing (Phase 3)Study completedNCT01773070
What this trial is testing

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Who this might be right for
Hepatitis C
AbbVie (prior sponsor, Abbott) 478
Large-scale testing (Phase 3)Study completedNCT01258686
What this trial is testing

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Who this might be right for
Hepatitis C
Bukwang Pharmaceutical 53
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Testing effectiveness (Phase 2)Study completedNCT02216045
What this trial is testing

Effect of Camel Milk on Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Mashhad University of Medical Sciences 40
Post-approval studies (Phase 4)Study completedNCT00530972
What this trial is testing

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Who this might be right for
Chronic Hepatitis CHIV Infections
Hospital Carlos III, Madrid 50
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Large-scale testing (Phase 3)UnknownNCT05854511
What this trial is testing

Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children

Who this might be right for
HCV
Ain Shams University 30
Large-scale testing (Phase 3)Study completedNCT01581398
What this trial is testing

Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Xiamen Amoytop Biotech Co., Ltd. 770
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation